Toursyn AI Closes Multi-Hundred-Million RMB Pre-A Rounds for AI Drug Design
Wuxi Toursyn AI raised multi-hundred-million RMB across Pre-A and Pre-A+ rounds to upgrade ToursynClaw, its one-stop AI drug-design platform. More deals: AI Investment.
© 版权声明
The copyright of the article belongs to the author, please do not reprint without permission.